Type 2 Diabetes

SAN DIEGO — Sodium-glucose cotransporter-2 inhibition may reduce the risk for gout by as much as 40% to 60% among certain patients with type 2 diabetes treated with metformin, according to data presented at ACR Convergence 2023.

Risk for developing colorectal cancer increased by 47% among individuals with type 2 diabetes, according to results from a cohort study designed to over-represent African Americans and low-income patients.

The FDA approved the injectable GIP/GLP-1 dual incretin-based agonist tirzepatide for chronic weight management among adults with obesity, according to a press release.

Adults with type 2 diabetes and obesity achieved greater weight loss with time-restricted eating at 6 months than with calorie restriction or continuing usual eating habits, according to study data.

Women living in low- and middle-income countries have a higher prevalence of obesity and other cardiometabolic disorders than men, according to findings published in The Journal of Clinical Endocrinology & Metabolism.

A man aged 51 years with a history of alcohol use disorder and type 2 diabetes treated with metformin and glimepiride and alcohol presented to the hospital for a witnessed cardiac arrest at home.

Consumption of red meat was linked to an increased risk for type 2 diabetes, whereas replacing red meat with dairy, nuts and legumes reduced that risk, according to a recent study.

BOSTON — Interventions that prevent or delay the onset of type 2 diabetes are critically important, and early diagnosis and treatment intensification can improve outcomes and increase lifespan, according to a speaker.

DALLAS — Oral semaglutide improves HbA1c and may prevent progression to type 2 diabetes for adults with prediabetes, according to a speaker at ObesityWeek.

BOSTON — Continuous glucose monitoring is becoming a mainstay of care for people with type 1 and type 2 diabetes, yet providers should be cautious about the technology’s application for people without diabetes looking for a “wellness” tool.